(Q42542282)

2 November 2017

title

Generalized seizures caused by fluoxetine overdose (English)

1 reference

2 November 2017

1 reference

1 reference

Gross R

1

1 reference

2 November 2017

Dannon PN

2

1 reference

2 November 2017

Lepkifker E

3

1 reference

2 November 2017

Zohar J

4

1 reference

2 November 2017

Kotler M

5

1 reference

2 November 2017

language of work or name

English

0 references

publication date

1 May 1998

1 reference

American Journal of Emergency Medicine

2 November 2017

published in

1 reference

2 November 2017

volume

16

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

328-329

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

2 November 2017

1 reference

7 January 2021

New antidepressant drugs and the seizure threshold

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Amoxapine overdose. Seizures and fatalities

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Fluoxetine, a selective serotonin uptake inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Fluoxetine-induced seizures

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Seizure associated with fluoxetine and adjuvant buspirone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Grand mal seizures associated with the use of fluoxetine.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Acute fluoxetine overdose: a report of 234 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Fluoxetine overdose in an adolescent

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Current concepts in the pharmacological treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

The effects of fluoxetine in the overdose patient

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Fluoxetine overdose: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Report of a fluoxetine fatality

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Anticonvulsant effect of fluoxetine on focally evoked limbic motor seizures in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Combined inhibition of serotonin uptake and oxidative deamination attenuates audiogenic seizures in DBA/2J mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

Fluoxetine and neuroleptic malignant syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0735-6757%2898%2990118-8

7 January 2021

10.1016/S0735-6757(98)90118-8

Identifiers

DOI

1 reference

2 November 2017

1 reference